drugset / Trial / NCT00142272
Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial
Phase 3
Completed
180 enrolled
International Centre for Diarrhoeal Disease Research, Bangladesh
Bayer · collabNEMC · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The study will be conducted to compare the efficacy and safety of a single dose of ciprofloxacin oral suspension 20 mg/kg with a 3-day course of erythromycin oral suspension administered in a dose of 12.5 mg/kg every 6 hours (12 doses) in the treatment of children, aged 2-15 years with clinically severe cholera due to V. cholerae O1 or O139. We hypothesize that single dose ciprofloxacin would result in similar outcome in the clinicalcurewith that of erythromycin given in multiple doses.
Timeline
- Start
- 2001-05
- Primary completion
- —
- Completion
- 2002-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciprofloxacin | Small molecule | 20 mg/kg | Oral |